Cargando…

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

Detalles Bibliográficos
Autores principales:	Qualls, David, Jacobson, Caron A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Inside Blood Advances
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388576/ https://www.ncbi.nlm.nih.gov/pubmed/37450319 http://dx.doi.org/10.1182/bloodadvances.2023009834

Ejemplares similares

Natalizumab for GVHD: too little or too late?
por: Quann, Kevin, et al.
Publicado: (2023)

This CAR won’t start: predicting nonresponse in ALL
por: Webster, Jonathan A., et al.
Publicado: (2023)

On a collision course: SARS-CoV-2 variants and CAR T cells
por: Auletta, Jeffery J.
Publicado: (2023)

The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023)

ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023)

Small but mighty: T-replete cords for myeloid disease
por: LaBelle, James L.
Publicado: (2023)

Further evidence supporting the global use of hydroxyurea
por: Archer, Natasha M.
Publicado: (2023)

Blood stem cell grafts: frozen is fine, but fresh is best
por: Horwitz, Mitchell E.
Publicado: (2023)

More evidence for low-dose IL-2 for chronic GVHD in children
por: Levine, John E.
Publicado: (2023)

Diagnosing TMAs by automated red cell morphology analyses
por: Billett, Henny H., et al.
Publicado: (2023)

Peripheral megakaryocytes sound the alarm in COVID-19
por: Boilard, Eric, et al.
Publicado: (2023)

Haplo ever after: haplo PTCy for children
por: Talano, Julie-An, et al.
Publicado: (2023)

Histidine-rich glycoprotein: antithrombosis without bleeding
por: Schmaier, Alvin H.
Publicado: (2023)

A wholesale approach to disarm multiple myeloma
por: Cenci, Simone
Publicado: (2023)

Autologous transplant and second malignancies in MM
por: Pasvolsky, Oren, et al.
Publicado: (2023)

It’s high time to turn the spotlight on HbSC disease
por: Oluwole, Olubusola, et al.
Publicado: (2023)

ICANS prophylaxis: potentially transformative but elusive
por: Dowling, Mark R., et al.
Publicado: (2023)

Cord blood power and the definition of success after BMT
por: Boelens, Jaap Jan, et al.
Publicado: (2022)

Curing CLL: one clone at a time
por: Aslan, Burcu, et al.
Publicado: (2022)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

A few sick men in a golf car? Burned-out practitioners in a burned-out world
por: Omar, Amr S., et al.
Publicado: (2021)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021)

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
por: Dhakal, Binod, et al.
Publicado: (2021)

On the Inside
por: Minorsky, Peter V.
Publicado: (2021)

On the inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

New indications and platforms for CAR‐T therapy in lymphomas beyond DLBCL
por: Iqbal, Madiha, et al.
Publicado: (2021)

The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020)

COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients
por: Oh, Bernice Ling Zhi, et al.
Publicado: (2022)

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
por: Rentsch, Vera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ofg4n8av8201plandaioq2n4b8